EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

An Evidence-Based Approach to the Diagnosis and Management of Seborrheic Dermatitis: A Systematic Review

Lisa Anggraini

The International Journal of Medical Science and Health Research · 09.04.2026 · 40 (1) · 57-107

DOI: 10.70070/2w2r9t25 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The International Journal of Medical Science and Health Research, online erschienen am 09.04.2026. Verfasst von Lisa Anggraini. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Seborrheic dermatitis (SD) is a prevalent, chronic inflammatory skin disorder with a significant impact on patient quality of life. Its pathogenesis is multifactorial, involving an interplay between Malassezia yeast, host immune response, and skin barrier integrity. While numerous treatments exist, an updated synthesis is needed to integrate novel therapies into the clinical management algorithm. This systematic review aims to critically appraise and synthesize high-level evidence from randomized controlled trials (RCTs) on the efficacy and safety of interventions for SD in adolescents and adults.

Methods

A systematic search of PubMed, Google Scholar, Semanthic Scholar, Springer, Wiley Online Library was conducted to identify RCTs evaluating pharmacological or procedural interventions for SD. Studies were selected based on pre-defined inclusion criteria. Data on study design, patient characteristics, interventions, and outcomes were extracted. The methodological quality of included studies was assessed using the Cochrane Risk of Bias tool.

Results

Seventeen RCTs met the inclusion criteria. The evidence confirms the efficacy of first-line topical therapies, including antifungals (ketoconazole, ciclopirox) and anti-inflammatory agents (corticosteroids, calcineurin inhibitors). Ketoconazole 2% formulations are consistently superior to vehicle (e.g., treatment success of 25.3% vs. 13.9%, P=0.0014) and prophylactic use reduces relapse. Ciclopirox demonstrates non-inferiority and, in some cases, superiority to ketoconazole in maintenance phases. The novel phosphodiesterase-4 (PDE-4) inhibitor, roflumilast 0.3% foam, demonstrated significantly higher rates of Investigator Global Assessment (IGA) Success compared to vehicle at week 8 (79.5% vs. 58.0%; P

Zitieren

APA

Anggraini, L. (2026). An Evidence-Based Approach to the Diagnosis and Management of Seborrheic Dermatitis: A Systematic Review. The International Journal of Medical Science and Health Research, 40(1), 57-107. https://doi.org/10.70070/2w2r9t25

Vancouver

Anggraini L. An Evidence-Based Approach to the Diagnosis and Management of Seborrheic Dermatitis: A Systematic Review. The International Journal of Medical Science and Health Research. 2026;40(1):57-107. doi:10.70070/2w2r9t25

BibTeX
@article{Anggraini2026,
  author = {Anggraini, Lisa},
  title = {An Evidence-Based Approach to the Diagnosis and Management of Seborrheic Dermatitis: A Systematic Review},
  journal = {The International Journal of Medical Science and Health Research},
  year = {2026},
  volume = {40},
  number = {1},
  pages = {57--107},
  doi = {10.70070/2w2r9t25}
}
Kostenlos starten →